RU2007104249A -
ANTI-DIABETIC AGENT WITH HYPOLIPIDEMIC ACTIVITY FOR TREATMENT AND PREVENTION OF TYPE II DIABETES
- Google Patents
ANTI-DIABETIC AGENT WITH HYPOLIPIDEMIC ACTIVITY FOR TREATMENT AND PREVENTION OF TYPE II DIABETES
Download PDF
Info
Publication number
RU2007104249A
RU2007104249ARU2007104249/15ARU2007104249ARU2007104249ARU 2007104249 ARU2007104249 ARU 2007104249ARU 2007104249/15 ARU2007104249/15 ARU 2007104249/15ARU 2007104249 ARU2007104249 ARU 2007104249ARU 2007104249 ARU2007104249 ARU 2007104249A
Общество с ограниченной ответственностью "КОМИБИОФАРМ" (RU)
Общество с ограниченной ответственностью "КОМИБИОФАРМ"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "КОМИБИОФАРМ" (RU), Общество с ограниченной ответственностью "КОМИБИОФАРМ"filedCriticalОбщество с ограниченной ответственностью "КОМИБИОФАРМ" (RU)
Priority to RU2007104249/15ApriorityCriticalpatent/RU2337698C1/en
Publication of RU2007104249ApublicationCriticalpatent/RU2007104249A/en
Application grantedgrantedCritical
Publication of RU2337698C1publicationCriticalpatent/RU2337698C1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Claims (1)
Противодиабетическое средство с гиполипидемической активностью для лечения и профилактики сахарного диабета II типа, содержащее экдистероидсодержащую субстанцию, выделенную из надземной части растений серпухи венценосной Serratula coronata L. (Asteraceae), представляющей собой смесь 20-гидоксиэкдизона в количестве не менее 75% и 25S-инокостерона в количестве не менее 10%.An antidiabetic agent with hypolipidemic activity for the treatment and prevention of type II diabetes mellitus, containing an ecdysteroid-containing substance isolated from the aerial part of the plants of the crown-bearing Serratula coronata L. (Asteraceae), which is a mixture of 20-hydroxyecdysone in an amount of at least 75% and 25S inocoster amount not less than 10%.
RU2007104249/15A2007-02-062007-02-06Antidiabetic agent with hypolipidemic activity for treatment and prevention of insular diabetes ii type
RU2337698C1
(en)
Общество С Ограниченной Ответственностью "Луфатен"
Clathrate complex of arabinogalactan or arabic gum with 20-hydroxyecdysones, method for producing it (versions), pharmaceutical composition and medicinal product
COMPOUNDS DERIVED FROM PIRIMIDO- [4,5-B] -OXAZINAS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF MELLITUS DIABETES AND / OR OBESITY.
COMPOUNDS DERIVED FROM INDOL; PREPARATION PROCEDURE; INTERMEDIARY COMPOUND; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF MELLITUS DIABETES, DIABETIC RETINOPATHY, HYPERGLUCEMIA, HYPERL
COMPOUNDS DERIVED FROM 1-BENZOIL-ISOQUINOLINAS SUBSTITUTED; PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OR PROFILAXIS OF TYPE II DIABETES.
Pharmaceutical composition comprising a sglt2 inhibitor and an insulin; and use to treat a disease or condition such as diabetes mellitus, diabetes mellitus type 1 and 2, among others.
COMPOUNDS DERIVED FROM N- (2-AZA-BICYCLE (3.1.0) HEX-3-ILMETIL) AMIDA; AND ITS USE TO PREVENT OR TREAT DEPRESSION, NEUROSIS, SCHIZOPHRENIA, ANXIETY, ADDICTIONS, EPILEPSY, PAIN, HEART DISEASES, AMONG OTHERS.
COMPOUNDS DERIVED FROM REPLACED BIPIRIDINE; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT AND / OR PROFILAXIS OF DISEASES SUCH AS HYPERTONIA, DIABETES, MYOCARDIAL INFARTS, BETWEEN OTHERS.
SUBSTITUTED SPIROCETAL DERIVATIVE COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND ITS USE FOR THE TREATMENT OF DIABETES, HYPERGLYCEMIA, DIABETIC COMPLICATIONS AND OBESITY.
PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMPOUND DERIVED FROM PIRAZOL-O-GLUCOSIDE COMBINED WITH AT LEAST A SECOND THERAPEUTIC AGENT; AND USE OF THE COMPOSITION FOR THE TREATMENT OF MELLITUS DIABETES, CATARATS, NEUROPATHY, MYOCARDIAL INFARTS, AND
Compounds derived from piperidine or pyrrolidine ureas; preparation procedure; pharmaceutical composition; and its use as modulators of the activity of 11ß-hydroxysteroid dehydrogenase type 1 (11ßhsd1) to treat obesity, diabetes, insulin resistance, cushing syndrome and hypertension, among others.
COMPOUNDS DERIVED FROM PIRIMIDINONE CONDENSED WITH HETEROCICLES; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, METABOLIC SYNDROME AND OBESITY.
COMPOSITION FOR THE PREVENTION OF DANIN ORGANISMS; METHOD FOR PREVENTION OF DANIN OR DANE ORGANISMS BY DANIN ORGANISMS; AND METHOD FOR PRESERVING A CROP OF A PLANT FOR AGRICULTURE.
COMPOUNDS DERIVED FROM INDOL INDANO; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT HYPERGLYCEMIA, TYPE 2 DIABETES, DETERIORATED GLUCOSE TOLERANCE, INSULIN RESISTANCE, X SYNDROME, DYSLIPIDEMIA.
Legal Events
Date
Code
Title
Description
MM4A
The patent is invalid due to non-payment of fees
Effective date:
20090207
NF4A
Reinstatement of patent
Effective date:
20120220
MM4A
The patent is invalid due to non-payment of fees
Effective date:
20130207
NF4A
Reinstatement of patent
Effective date:
20160210
PC41
Official registration of the transfer of exclusive right